Stay updated on SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial

Sign up to get notified when there's something new on the SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s footer revision label was updated from **Revision: v3.5.2** to **Revision: v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-24T06:28:21.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:49:19.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page. The old revision reference is no longer shown.
    Difference
    0.0%
    Check dated 2026-03-19T06:17:56.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3. The previous revision v3.4.2 has been superseded.
    Difference
    0.1%
    Check dated 2026-03-12T02:20:21.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    No substantive content additions or deletions were detected; the study details, eligibility criteria, and outcome measures remain unchanged.
    Difference
    0.0%
    Check dated 2026-03-04T23:58:17.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Revision indicator updated to v3.4.2 and the government funding status notice (including the prior Revision: v3.4.1) was removed; no study content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:39:23.000Z thumbnail image

Stay in the know with updates to SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial page.